Rapid aldosterone signaling and vascular reactivity: relax or don't do it.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation.Frontiers in pharmacology · 2015
   Article
2. Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease.Pflugers Archiv : European journal of physiology · 2013
   Review
3. Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation.Clinical and experimental pharmacology & physiology · 2013
   Review
4. Mineralocorticoid receptors in vascular function and disease.Molecular and cellular endocrinology · 2012
   Review

Corrections and comments

• Comment on
  Nitric oxide-mediated dilation of arterioles to intraluminal administration of aldosterone.2009

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as